DEVELOPMENT OF QUANTITATIVE METHODS FOR STUDYING ELECTROSTATIC COMPLEMENTARITY IN MOLECULAR RECOGNITION AND DRUG DESIGN

被引：0
|
作者：
DEAN, PM
CHAU, PL
BARAKAT, MT
机构：
来源：
JOURNAL OF MOLECULAR STRUCTURE-THEOCHEM | 1992年 / 88卷
关键词：
D O I：
暂无
中图分类号：
O64 [物理化学（理论化学）、化学物理学];
学科分类号：
070304 ; 081704 ;
摘要：
Statistical methods are provided for studying electrostatic complementarity between a macromolecular site and its ligand. The methods are tested on the protein ribonuclease T1 and the ligand 2'-guanosine monophosphate. Adjacent charges on the contact atoms between the site and the ligand do not show complementarity although strong complementarity is found between their electrostatic potential surfaces. The build-up of electrostatic complementarity, atom by atom, is traced. Complementarity appears to be a property of the whole and not simply related to constituent parts.
引用
收藏
页码：75 / 89
页数：15
相关论文
共 50 条
  • [21] DRUG DESIGN WITH A NEW-TYPE OF MOLECULAR MODELING BASED ON STEREOCHEMICAL COMPLEMENTARITY TO GENE STRUCTURE
    HENDRY, LB
    JOURNAL OF CLINICAL PHARMACOLOGY, 1993, 33 (12): : 1173 - 1187
  • [22] Quantitative Evaluation of Safety in Drug Development - Design, Analysis and Reporting
    Wang, William
    JOURNAL OF BIOPHARMACEUTICAL STATISTICS, 2015, 25 (05) : 1132 - 1133
  • [23] The role of the sulfaguanidine molecular scaffold in drug design and development
    Abulkhair, Hamada S.
    ARCHIV DER PHARMAZIE, 2025, 358 (01)
  • [24] Molecular Imaging As a Tool for Drug Development and Trial Design
    de Vries, Elisabeth G. E.
    de Jong, Steven
    Gietema, Jourik A.
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (24) : 2585 - U8
  • [25] Quantitative design methods for human sensory properties in automobile development
    Matsuoka, Y
    PROCEEDINGS OF THE FIRST CHINA-JAPAN JOINT INTERNATIONAL SYMPOSIUM ON INDUSTRIAL DESIGN, 1996, : 251 - 258
  • [26] Molecular recognition studies to advance structure-based drug design
    Diederich, Francois
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2018, 256
  • [27] Molecular recognition of protein-ligand complexes: applications to drug design
    Agouron Pharmaceuticals, Inc, San Diego, United States
    Chem Rev, 5 (1359-1472):
  • [28] A proposal for a new PhD level curriculum on quantitative methods for drug development
    Jaki, T.
    Gordon, A.
    Forster, P.
    Bijnens, L.
    Bornkamp, B.
    Brannath, W.
    Fontana, R.
    Gasparini, M.
    Hampson, L. V.
    Jacobs, T.
    Jones, B.
    Paoletti, X.
    Posch, M.
    Titman, A.
    Vonk, R.
    Koenig, F.
    PHARMACEUTICAL STATISTICS, 2018, 17 (05) : 593 - 606
  • [29] DEVELOPMENT OF QUANTITATIVE METHODS OF MEASURING ANTIFUNGAL DRUG EFFECTS IN THE RABBIT CORNEA
    OJI, EO
    BRITISH JOURNAL OF OPHTHALMOLOGY, 1981, 65 (02) : 89 - 96
  • [30] A proposal for a new PhD level curriculum on quantitative methods for drug development
    Jaki, Thomas
    Gordon, Allan
    Forster, Pamela
    Bijnens, Luc
    Bornkamp, Bjoern
    Brannath, Werner
    Fontana, Roberto
    Gasparini, Mauro
    Hampson, Lisa V.
    Jacobs, Tom
    Jones, Byron
    Paoletti, Xavier
    Posch, Martin
    Titman, Andrew
    Vonk, Richardus
    Koenig, Franz
    PHARMACEUTICAL STATISTICS, 2019, 18 (03) : 284 - 286
12345